Nanosonics Limited

NNCSFOTCHealthcare● Active

$2.07

+$0.00(+0.00%)

Market Cap$618556218

P/E Ratio—

52W High$3.0575

52W Low$2.01

Avg Volume123

Open$2.07

Beta1.21

Free Cash Flow Financials Revenue

Nanosonics Limited (NNCSF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

NNCSF · free cash flow · updated Jun 9, 2026

Core FCF metrics

NNCSF · FCF · TTM · margin & CAGR

Free cash flow was $35.3M for FY2025 (fiscal year ending 2025-06-30), up 74.0% year-over-year The FCF margin was 17.7%. Five-year CAGR stands at +11.1%.

FY2025 Free Cash Flow$35.3M▲ +74.0% YoY

Trailing 12M (TTM)$52.0Mtrailing 4 quarters sum

FCF Margin17.7%$35.3M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGR+11.1%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

NNCSF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$44.0M(9M)$35.3M▲ +74.0%17.7%

FY2024$22.8M(3M)$20.3M▲ +2.6%11.9%

FY2023$23.3M(4M)$19.7M▲ +7385.2%11.8%

FY2022$6.7M(7M)−$271,000▼ 104.6%-0.2%

FY2021$7.3M(1M)$5.9M▼ 71.5%5.8%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

NNCSF · P/FCF · FCF yield · FCF per share

Nanosonics Limited (NNCSF) trades at a FCF yield of 2.47% and a price-to-free-cash-flow ratio of 12.2x. FCF per share stands at $0.17, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

2.47%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.17

TTM FCF ÷ Shares Outstanding

Price / FCF

x12.2

Share Price ÷ FCF per Share

EV / FCF (TTM)

x34.3

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-06-30

Cash flow statement summary

NNCSF · cash flow statement · operating / investing / financing

For FY2025, Nanosonics Limited generated $44.0M in operating cash flow and spent 9M in capital expenditures, yielding $35.3M in free cash flow.

Operating Activities

+$44.0M

Cash from core business operations

2025-06-30

Investing Activities

−$8.7M

CapEx, acquisitions & investments

2025-06-30

Financing Activities

−$3.3M

Buybacks, dividends & debt

2025-06-30

FCF FormulaOperating CF ($44.0M) − |CapEx| (9M) = FCF ($35.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

NNCSF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Nanosonics LimitedYOU

NNCSF

$35.3M+74.0%17.7%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Nanosonics Limited (NNCSF) reported free cash flow of $35.3M for FY2025 (fiscal year ending 2025-06-30), up 74.0% year-over-year. The FCF margin was 17.7%.

Based on available data, Nanosonics Limited has maintained positive free cash flow for at least 9 fiscal year(s). FCF peaked at $35.3M in FY2025. The 5-year CAGR stands at +11.1%.

Nanosonics Limited's FCF yield is 2.47% and price-to-FCF ratio is 12.2x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

NNCSF free cash flow · 8 questions

Nanosonics Limited free cash flow was $35.3M for FY2025, up 74.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $52.0M.

NNCSF free cash flowNNCSF FCFNNCSF FCF 2025NNCSF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Nanosonics Limited · Nanosonics Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026